EastWest BioScience Group
Tuesday, November 14, 2017 - 1:59 PM EST

Harbour Star Capital QT Target EastWest Bioscience Signs Agreement with Amazon

EastWest BioScience signs agreement with Amazon, North America’s largest online distributor of nature health products for its Natural Advancement nutraceutical product line.

Richmond, British Columbia (FSCwire) - 1011705 B.C Ltd. (dba Eastwest BioScience) (“the Company” or “EastWest”} and Harbour Star Capital Corp. (“Harbour Star”) announce a distribution agreement between EastWest and Amazon, North America’s largest online distributor of natural health products. The Company is now set up on Amazon’s sales platform and expects to ship its Natural Advancement hemp-based nutraceutical products to Amazon in November.


Additionally, the Company signed an agreement with M2 Brand Management (“M2”) to promote EastWest’s Natural Advancement brand line and products to thousands of natural health products stores in Canada. M2 is headquartered in Montreal and is one of leading brand management companies for retail consumer products.


As a part of Eastwest’s strategic business plan, the Company has prioritized developing rich media content for its marketing for both traditional and social media marketing. It has brought together a strong in-house team to create its own content and to date has produced several videos to introduce Eastwest and the Natural Advancement brand.  You can see Natural Advancement Product Training Videos for more information on the products on the Company’s newly launched Vimeo channel.


The Company has also seen significant development of its nutraceutical product manufacturing division Orchard Valley Naturals (“OVN”). OVN is a new Health Canada licensed facility operating in the company’s recently acquired facility in Pentiction, BC. The same OVN facility was occupied by Planet Organic only a few years ago and has the capacity to manufacture significant varieties and volumes of nutraceutical products.


Amalgamation Update


Harbour Star and EastWest have completed their mutual due diligence and are preparing documentation for submission to the TSX Venture Exchange.  The closing of the Amalgamation is subject to satisfaction or waiver of terms and conditions, customary or otherwise, including all other applicable approvals including but not limited to the approval of the TSXV. There can be no assurance that the Amalgamation will be completed as proposed or at all.


About EastWest BioScience Inc.


1011705 B.C Ltd. doing business as EastWest Bioscience Inc., a life science consumer products company manufacturing, marketing, and distributing hemp-based products. EastWest is headquartered in Richmond, British Columbia, with a manufacturing, laboratory and warehouse facility located in Penticton, British Columbia.


For further information about EastWest, please contact:


Darrell Woronchak

Investor Relations

Telephone: (800) 409-1930, Ext 200


About Harbour Star Capital Corp.


Harbour Star is a capital pool corporation listed on the TSX-V (“HSC”) and has signed a definitive agreement to complete a transaction with Eastwest BioScience Inc. as its proposed Qualifying Transaction. Please see the press releases dated June 2, 2017 and September 1, 2017. 


For further information about Harbour Star, please contact:


Mohammad Fazil

President and Chief Executive Officer

Telephone: (403) 613-7310

All information contained in this news release with respect to Harbour Star and EastWest was supplied by the parties respectively for inclusion herein.


Completion of the Transaction is subject to a number of conditions, including but not limited to, approval by shareholders of EastWest and HSC, if necessary, completion of the Financing and acceptance of the Transaction by the TSX Venture Exchange.  Where applicable, the Transaction cannot close until the required shareholder approval is obtained.  There can be no assurance that the Transaction will be completed as proposed or at all.


Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon.  Trading in the securities of a capital pool company should be considered highly speculative.


The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view this press release as a PDF file, click onto the following link:

Source: Harbour Star Capital Inc. (TSX Venture:HSC.P)

To follow Harbour Star Capital Inc. on your favorite social media platform or financial websites, please click on the icons below.


Maximum News Dissemination by FSCwire. http://www.fscwire.com


Copyright © 2017 Filing Services Canada Inc.

Visit Company Profile EastWest BioScience Group
Visit Company Website
Subscribe to This Company Sign Up